Lactose giant DMV-Fonterra to buy Indian cellulose excipient maker Brahmar
31-Aug-2011 By Gareth Macdonald
DMV-Fonterra excipients (DFE) will buy Indian manufacturer Brahmar Cellulose Private Limited (BCPL) to strengthen its position in the pharmaceutical excipient market and reduce costs.
Wacker expands sales presence in ‘high priority’ Indian market
31-Aug-2011 By Gareth Macdonald
German chemical maker Wacker Chemie is ramping up its sales operations in India, with the country’s rapidly expanding pharmaceutical sector being one of its key targets.
inVentiv plans Asian expansion
31-Aug-2011 By Nick Taylor
inVentiv Health is looking to expand operations in Japan, China and India after completing takeovers of i3 and PharmaNet.
OpenClinica ink Athena deal to distribute clinical trial software in China
30-Aug-2011 By Natalie Morrison
Open source clinical trial software company OpenClinica has launched a marketing agreement with Athena Healthcare Consultancy to work within the Chinese market.
30-Aug-2011 By Gareth Macdonald
Chemicals giant BASF has increased the price of drug APIs and excipients by 10 per cent for the second time in a year.
Granules to expand API and intermediate capacity
update
29-Aug-2011 By Gareth Macdonald
Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.
Over 50% of sales at top CROs now made outside US; report
29-Aug-2011 By Nick Taylor
Big public CROs now generate more than half their collective revenue outside the US after triple-digit growth in recent years, a report found.
inVentiv revamps European comms ops to better compete
29-Aug-2011 By Gareth Macdonald
inVentiv Health says European communications group’s new ‘super agency’ structure will help it to compete in a market dominated by large multi-nationals.
New plant moves Irvine into Asia, gives it 2nd media source
25-Aug-2011 By Nick Taylor
Irvine Scientific has begun shipping from the cell culture media plant it built to expand into Asia and give clients the security of a second source.
Ashland completes ISP takeover and predicts customer benefits
25-Aug-2011 By Gareth Macdonald
US chemicals maker Ashland says completion of ISP takeover means simplified supply chains for drug and cosmetics industry customers.
CRL names new regional heads of combined RMS-PCS units
24-Aug-2011 By Gareth Macdonald
US CRO Charles River Laboratories (CRL) has rejigged its upper management as part of a business realignment that unifies its regional research model and preclinical development businesses.
Foreign investment needed to boost UAE drug production
24-Aug-2011 By Nick Taylor
The UAE needs overseas investment to kick-start its pharmaceutical manufacturing sector and end reliance on foreign imports, the DCCI says.
Clinigene and Spaulding team up on pharmacology services
23-Aug-2011 By Gareth Macdonald
Biocon’s Indian unit Clinigene International has partnered with US counterpart Spaulding Clinical Research LLC to provide clinical pharmacology services.
Brazil & USP ink deals to up quality, harmonise standards
23-Aug-2011 By Nick Taylor
The USP is strengthening ties to the Brazilian pharmaceutical sector to improve quality and drive harmonisation of standards.
Rise of Chinese pharma helps ShangPharma grow in Q2
23-Aug-2011 By Nick Taylor
China-based clients now account for 10 per cent of ShangPharma revenues after successive quarters of triple-digit sales growth.
CMOs in India & China look to grow international business
22-Aug-2011
JB Chemicals and Asymchem Laboratories are expanding in response to interest in outsourcing manufacturing to India and China.
EMA aims to spark debate on quality in clinical trials
22-Aug-2011 By Gareth Macdonald
The EMA says current GCP rules make quality management in trials too costly and need to be revised into a code that meets the needs of academics, small and midsized drugmakers and Big Pharmas alike.
MakroCare teams with LSK Global for further Asian expansion
18-Aug-2011 By Gareth Macdonald
US-headquartered trial services firm MakroCare has continued its expansion in Asia with a new partnership with South Korea-based CRO LSK Global.
18-Aug-2011 By Nick Taylor
The US FDA has warned that rapid patient enrolment in emerging markets can overload sites that lack the staff to oversee data as it is generated.
Russia's trial approval rate drops for second consecutive quarter; more resources needed says Synergy
17-Aug-2011 By Gareth Macdonald
Russian authorities need to dedicate more resources to reviewing trial applications ahead of new site accreditation rules due to come into effect later this year according to report on the country’s contract research sector.
LatAm investigators prefer pharma, not CRO, run trials
17-Aug-2011 By Nick Taylor
Latin American investigators prefer pharma companies, as opposed to CROs, to handle day-to-day clinical trials operations, according to a survey.
WuXi adding clinical services to open China to clients
16-Aug-2011 By Nick Taylor
WuXi is entering the Chinese clinical trial services sector to help international clients introduce products in the high-growth country.
FDA issues with CRO-run trial in Argentina set back Adventrx
11-Aug-2011 By Nick Taylor
Adventrx faces having to redo its pivotal bioequivalence study after the FDA raised concerns about its CRO-managed trial in Argentina.
Biopharm turning to 3PL & global suppliers for savings
11-Aug-2011 By Nick Taylor
Close to two-thirds of biopharm companies plan to increase reliance on 3PL providers and global manufacturers in coming years, a survey found.
GSK signs packaging deal in Iraq
09-Aug-2011 By Natalie Morrison
GlaxoSmithKline (GSK) has won its four-year battle to start packaging drugs in Iraq by outsourcing production to a local company.
Big pharma thirst for pre-IND services driving CRL deals
08-Aug-2011 By Nick Taylor
Charles River is hunting for acquisitions with capabilities to meet big pharma’s newfound interest in discovery services.
HP launches ‘cloud’ track and trace system to help fight counterfeits
04-Aug-2011 By Gareth Macdonald
HP has launched a global authentication service it says will help identify counterfeit and stolen pharmaceuticals.
Excipient capacity & portfolio expansion in FMC plans
04-Aug-2011 By Nick Taylor
FMC plans to add controlled release technologies and expand excipient production to drive growth at its BioPolymer unit.
DSM seeks CMO partner to diversify beyond big pharma
04-Aug-2011 By Nick Taylor
DSM wants to form a CMO joint venture to become less reliant on big pharma clients and revive the flagging business unit.
EDQM to work on Chinese medicine quality monographs
03-Aug-2011 By Gareth Macdonald
The EDQM will work to improve the quality of traditional Chinese medicines (TCM) sold in Europe under a memorandum of understanding (MoU) with SATCM.
03-Aug-2011 By Gareth Macdonald
Quintiles says the Russian pharmaceutical market is at a tipping point and poised for significant expansion over the next decade.
03-Aug-2011 By Nick Taylor
The FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials.
02-Aug-2011 By Gareth Macdonald
The EDQM has suggested Google Earth as a potential source of GPS co-ordinate data for manufacturing sites that must be supplied in CEP applications under recently introduced requirements.
Aenova leases SkyePharma plant in a bid to conquer US tablet market
02-Aug-2011 By Natalie Morrison
Aenova will take control of SkyePharma tablet production site in a bid to rank in the top European manufacturers.
28-Jul-2011 By Gareth Macdonald
INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.
PPD says income and revs grew in Q2 but analysts unconvinced
update
27-Jul-2011 By Gareth Macdonald
PPD posted an improved set of financials for Q2 days after announcing a review of its long-term plan and capital structure following speculation it was looking for a buyer.
CDSCO issues new Form 40 draft guidance for API importers
25-Jul-2011 By Gareth Macdonald
India’s CDSCO has issued draft guidance designed to help active pharmaceutical ingredient (API) importers streamline the submission and registration process.
Distribution deals to TAP into SE Asia bioprocessing sector
21-Jul-2011 By Nick Taylor
TAP Biosystems has inked deals with six distributors in South East Asia to extend sales support for its automated bioprocessing systems.
ClinStar expands in US with East Coast office
21-Jul-2011 By Natalie Morrison
Emerging market CRO ClinStar has lengthened its US reach with a new regional East Coast office.
Pall solidifies long-term Engefiltro relationship in take-over
20-Jul-2011 By Natalie Morrison
Filtration, separation and purification technology company Pall is to acquire its long-time Brazilian distribution partner, Engefiltro.
Granules and Ajinomoto OmniChem to open Indian API facility
19-Jul-2011 By Natalie Morrison
Granules and Ajinomoto OmniChem have teamed up to produce high value APIs and intermediates at a new Indian plant.
18-Jul-2011 By Nick Taylor
Europe has proposed draft distribution guidance in response to globalisation and threats to the pharmaceutical supply chain.
Tamper evident devices must be traceable & unique; Rx-360
18-Jul-2011 By Nick Taylor
Physical endurance, traceability and uniqueness are key characteristics for tamper evident devices used in raw material supply, according to Rx-360.
FDA must be empowered to oversee supply chain; report
13-Jul-2011 By Nick Taylor
Congress must grant the FDA additional powers to bring oversight of manufacturing inline with shifts in production practices, according to a report.
12-Jul-2011 By Nick Taylor
Phillips Plastics is to expand into Europe and add primary packaging contract manufacturing capabilities by acquiring Medisize.
12-Jul-2011 By Nick Taylor
Cash-strapped countries are making biopharm consider a product’s fiscal benefits earlier in development, according to INC.
EU should revoke licenses if emission caps exceeded; report
11-Jul-2011 By Nick Taylor
Production plants exceeding emission levels could have manufacturing authorisations revoked under EU GMP proposals made by Sweden.
Gerresheimer wants to buy into US plastic packaging sector
06-Jul-2011 By Gareth Macdonald
Gerresheimer is interested in a US acquisition as part of a bid to build in the North American plastic drug packaging sector.
WTO rules against China in raw material export quota case
06-Jul-2011 By Nick Taylor
A WTO panel has ruled China’s export limits on raw materials, including some with pharma uses, are unfair after claims they drive up prices.
Protocols and planning key to avoiding warning letters; FDA
05-Jul-2011 By Nick Taylor
Better designed protocols and early identification of risks can improve trial quality and help avoid warning letters, said the FDA.